News
Google News: This week: A world first for Bglobal, a Quarto-ly update and Ark increases ...
[Proactive Investors UK] - Verona Pharma (LON:VRP) Verona Pharma, the Company focused on discovering and developing first-in-class drugs for respiratory disease, today announced the appointment of Dr Sven Jan-Anders Karlsson (aged 57) as Chief Executive Officer with effect from
Verona Pharma appoints Dr Sven Jan-Anders Karlsson as CEO
www.pmlive.com
[PMLiVE] - Verona Pharma has appointed Dr Sven Jan-Anders Karlsson to be the respiratory-focused biotech's new CEO. He replaces Michael Walker, one of the UK-based company's co-founders, who is stepping down from his position but will remain as a senior
Verona Pharma names Dr Sven Karlsson as new CEO, replacing Michael Walker
www.rttnews.com
[RTT News] - L) Tuesday announced that it has appointed Dr Sven Jan-Anders Karlsson as the Chief Executive Officer of the company with effect from 1st June The company, focused on discovering and developing first-in-class drugs for respiratory disease
Singapore drug-development firm receives "orphan" approval from US |...
topnews.in
... a tax credit on cost of clinical trials performed in the US," The Business Times quoted chief executive officer Jan-Anders Karlsson as saying.
sorted by relevance / date